Pain in the brain: Are hormones to blame?

Trends in Endocrinology and Metabolism

Volumn 14, Issue 1, 2003, Pages 20-27

  Blackburn Munro, Gordon ^a   Blackburn Munro, Ruth ^b  

^a NeuroSearch ^*  (Denmark)

^b H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDEPRESSANT AGENT; CYTOKINE; DEXAMETHASONE; GROWTH HORMONE RELEASING FACTOR; HORMONE; MELATONIN; MELATONIN RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN A; OREXIN B; PROTON; SEROTONIN AGONIST; SEX HORMONE; SOMATOMEDIN C; SOMATOSTATIN; VASOPRESSIN;

BRAIN; COST; DEPRESSION; EMOTION; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LIMBIC SYSTEM; MOOD DISORDER; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SENSORY NERVE CELL; SPINAL CORD;

ADRENAL GLANDS; AFFECT; ANIMALS; BRAIN; CHRONIC DISEASE; FEMALE; GROWTH HORMONE; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIMBIC SYSTEM; MALE; MELATONIN; NEURONS, AFFERENT; PAIN; SEX FACTORS; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 0038745799     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00004-8     Document Type: Review

References (57)

1. Fishbain, D.A. et al. (1997) Chronic pain-associated depression: antecedent or consequence of chronic pain. A review. Clin. J. Pain 13, 116-137
2. Blackburn-Munro, G. and Blackburn-Munro, R.E. (2001) Chronic pain, chronic stress and depression: coincidence or consequence? J. Neuroendocrinol. 13, 1009-1023
3. Hansson, P. et al. (2001) Aspects of clinical and neuropathic pain: the clinical perspective. In Neuropathic Pain: Pathophysiology and Treatment (Hansson, P.T. et al., eds), pp. 1-18, IASP
4. Woolf, C.J. and Salter, M.W. (2000) Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1768
5. Juilius, D. and Basbaum, A.I. (2001) Molecular mechanisms of nociception. Nature 413, 203-210
6. Millan, M.J. (1999) The induction of pain: an integrative review. Prog. Neurobiol. 57, 1-164
7. Price, D.D. (2000) Psychological and neural mechanisms of the affective dimension of pain. Science 288, 1769-1772
8. Ruoff, G.E. (1996) Depression in the patient with chronic pain. J. Fam. Pract. 43 (Suppl.), S25-S34
9. Arner, S. and Meyerson, B.A. (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11-24
10. Backonja, M. (2001) Anticonvulsants and antiarrhythmics in the treatment of neuropathic pain syndromes. In Neuropathic Pain: Pathophysiology and Treatment (Hansson, P.T. et al., eds), pp. 185-201, IASP
11. Sindrup, S.H. and Jensen, T.S. (2001) Antidepressants in the treatment of neuropathic pain. In Neuropathic Pain: Pathophysiology and Treatment (Hansson, P.T. et al., eds), pp. 169-183, IASP
12. Tramer, M.R. et al. (1998) Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol. Scand. 42, 71-79
13. Herman, J.P. and Cullinan, W.E. (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20, 78-84
14. Chrousos, G. (2000) Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol. 106, S275-S291
15. Aguilera, G. (1994) Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15, 321-350
16. Habib, K. et al. (2001) Neuroendocrinology of stress. Endocrinol. Metab. Clin. North. Am. 30, 695-728
17. Clauw, D.J. and Chrousos, G.P. (1997) Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4, 143-153
18. Sternberg, E.M. et al. (1989) Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl Acad. Sci. USA 86, 2374-2378
19. Chikanza, I.C. et al. (2000) Perturbations of arginine vasopressin secretion during inflammatory stress: pathophysiologic implications. Ann. NY Acad. Sci. 917, 825-834
20. Shanks, N. et al. (1998) Inflammatory disease as chronic stress. Ann. NY Acad. Sci. 840, 599-607
21. Harbuz, M.S. (1999) Chronic inflammatory stress. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 13, 555-565
22. Bijlsma, J.W.J. et al. (1999) The neuroendocrine immune basis of rheumatic diseases. Immunol. Today 20, 298-301
23. Parker, A.J.R. et al. (2001) The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol. Med. 31, 1331-1345
24. Crofford, L.J. (1998) The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z. Rheumatol. 57, 67-71
25. Lentjes, E.G.W.M. et al. (1997) Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 22, 603-614
26. Neeck, G. and Riedel, W. (1999) Hormonal perturbations in fibromyalgia syndrome. Ann. NY Acad. Sci. 876, 325-339
27. Neeck, G. (2000) Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia. Scand. J. Rheumatol. Suppl. 113, 8-12
28. Gabry, K.E. et al. (2002) Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Mol. Psychiatry 7, 474-483
29. Eliav, E. et al. (1999) Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain 83, 169-182
30. Benoliel, R. et al. (2002) Strain-dependent modification of neuropathic pain behaviour in the rat hindpaw by a priming painful trigeminal injury. Pain 97, 203-212
31. Leonard, B.E. (2001) Stress, norepinephrine and depression. J. Psychiatry Neurosci. 26 (Suppl.), S11-S16
32. Berkley, K.J. (1997) Sex differences in pain. Behav. Brain Sci. 20, 371-380
33. Fillingham, R.B. and Ness, T.J. (2000) Sex-related hormonal influences on pain and analgesic responses. Neurosci. Biobehav. Rev. 24, 485-501
34. Shughrue, P.J. et al. (1997) Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525
35. Liuzzi, F.J. et al. (1999) Effects of short-term oestrogen replacement on trkA mRNA levels in axotomized dorsal root ganglion neurons. Exp. Neurol. 159, 433-440
36. Coyle, D.E. et al. (1995) Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model. Neurosci. Lett. 186, 135-138
37. Coyle, D.E. et al. (1996) Intact female rats are more susceptible to the development of tactile allodynia than ovariectomized female rats following partial sciatic nerve ligation (PSNL). Neurosci. Lett. 203, 37-40
38. Green, P.G. et al. (2001) Role of adrenal medulla in development of sexual dimorphism in inflammation. Eur. J. Neurosci. 14, 1436-1444
39. Keogh, E. and Herdenfeldt, M. (2002) Gender, coping and the perception of pain. Pain 97, 195-201
40. Soares, C.N. et al. (2002) Hormone treatment for mood disorders in women. Expert Rev. Neurotherapeut. 2, 25-34
41. López-Bermejo, A. et al. (2000) Genetic defects of the growth hormone-insulin-like growth factor axis. Trends Endocrinol. Metab. 11, 39-49
42. Leal-Cerro, A. et al. (1999) The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J. Clin. Endocrinol. Metab. 84, 3378-3381
43. Bitar, M.S. and Pilcher, C.W.T. (1998) Attenuation of IGF-I anti-nociceptive action and a reduction in spinal cord gene expression of its receptor in experimental diabetes. Pain 75, 69-74
44. Zhuang, H.-X. et al. (1996) Insulin-like growth factors reverse or arrest diabetic neuropathy: effect on hyperalgesia and impaired nerve regeneration in rats. Exp. Neurol. 140, 198-205
45. Yu, C.-X. et al. (2000) The analgesic effects of peripheral and central administration of melatonin in rats. Eur. J. Pharmacol. 403, 49-53
46. Laurido, C. et al. (2002) Effect of melatonin on rat spinal nociceptive transmission. Neuroreport 13, 89-91
47. Raghavendra, V. et al. (2000) Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur. J. Pharmacol. 395, 15-21
48. Brzezinski, A. (1997) Melatonin in humans. N. Engl. J. Med. 336, 186-195
49. Huether, G. et al. (1993) Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats. Eur. J. Pharmacol. 238, 249-254
50. Roberts-Thompson, I.C. et al. (1988) Circadian rhythms in patients with abdominal pain syndromes. Aust. NZ J. Med. 18, 569-574
51. Almay, B.G. et al. (1987) Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res. 22, 179-191
52. Waldenlind, E. et al. (1987) Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neurol. Neurosurg. Psychiatry 50, 207-213
53. Sutcliffe, J.G. and de Lecca, L. (2002) The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3, 339-349
54. Grudt, T.J. et al. (2002) Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat. J. Physiol. 538, 517-525
55. Bingham, S. et al. (2001) Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92, 81-90
56. Merskey, H. (1994) In Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Pain Terms, 2nd edn, (Bogduk, N., ed.), IASP
57. Cheng, H.-Y. et al. (2002) DREAM is a critical transcriptional repressor for pain modulation. Cell 108, 31-43